443 related articles for article (PubMed ID: 10188144)
1. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
2. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
Leynadier F; Duarte-Risselin C; Murrieta M
Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
[TBL] [Abstract][Full Text] [Related]
3. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
[TBL] [Abstract][Full Text] [Related]
6. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
[TBL] [Abstract][Full Text] [Related]
7. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR
Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
[TBL] [Abstract][Full Text] [Related]
9. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
Monroe EW
Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
[TBL] [Abstract][Full Text] [Related]
12. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
13. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
[TBL] [Abstract][Full Text] [Related]
15. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E
Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385
[TBL] [Abstract][Full Text] [Related]
16. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study.
Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Ratner P; Hampel F; Van Bavel J; Howland W
Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
[TBL] [Abstract][Full Text] [Related]
18. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
19. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
20. Rapid symptom relief in rhinitis.
Bousquet J
Clin Exp Allergy; 1999 Mar; 29 Suppl 1():25-9. PubMed ID: 10209702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]